Skip to content
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Menu
Search
Toggle Menu
Change Country
Our Stories
Latest News
Innovation
Caring & Giving
Personal Stories
Health & Wellness
Our Heritage
Our Company
About J&J
Our Credo
Our Leadership Team
Code of Business Conduct
Corporate Reports
Diversity, Equity & Inclusion
ESG Policies & Positions
Innovation at J&J
J&J Health and Wellness Solutions
Office of the Chief Medical Officer
Veterans, Military & Military Families
Products
MedTech
Pharmaceutical Products
Suppliers
Responsibility Supply Base
Supplier-Enabled Innovation
Supplier Resources
Careers
What We Do
How We Hire
Job Spotlight
Employee Benefits
Students
Innovation
Career Stories
Media Center
Investors
2023 Annual Meeting of Shareholders
Corporate Governance
Quarterly Results
SEC Filings
News Releases
Pharmaceutical Pipeline
2022 Janssen Transparency Report
2021 Health for Humanity Report
ESG Investor Update
ESG Resources
Stock Information
Webcasts & Presentations
Investor Fact Sheet
Our Societal Impact
Global Community Impact
Global Public Health
Global Environmental Sustainability
Close Countries Menu
Explore more Johnson & Johnson sites:
China
France
Germany
India
Japan
Russia
Switzerland
German
English
French
United Kingdom
United States
Close Search Menu
Search input
Share
Investor Information
Get the latest news, conference announcements, press releases and company performance information to be an informed shareholder.
Johnson & Johnson to Participate in the Goldman Sachs 44
th
Annual Global Healthcare Conference
Johnson & Johnson to Participate in the Goldman Sachs 44
th
Annual Global Healthcare Conference
Register Here
Listen to Webcast: Bernstein 39th Annual Strategic Decisions Conference
Listen to Webcast: Johnson & Johnson First Quarter 2023 Earnings Call
Listen to Webcast: Johnson & Johnson at the Barclays Global Healthcare Conference
NYSE: JNJ
$155.06
$0.69 (
0.450
%)
Day High
$155.69
Day Low
$153.85
Volume
11,323,560
Last Updated:
5/31/2023 04.10 PM
2023 Annual Meeting of Shareholders
2023 Annual Meeting of Shareholders
Annual Meeting Materials and Webcast
Consumer Health Separation: Johnson & Johnson Shareholder Frequently Asked Questions
Consumer Health Separation: Johnson & Johnson Shareholder Frequently Asked Questions
Learn More
Latest News Releases
Latest News
May 10, 2023
Johnson & Johnson to Participate in the Goldman Sachs 44
th
Annual Global Healthcare Conference
Financial
May 03, 2023
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
Latest News
April 30, 2023
Janssen Reports First Results from Phase 2 SunRISe-1 Study of TAR-200 and Anti- PD-1 Antibody Cetrelimab in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer
See All News Releases
ON NOW
Webcast: Pharmaceutical Business Review 2021
Webcast: Pharmaceutical Business Review 2021
Webcast: Pharmaceutical Business Review 2021
ON NOW
2021 Health for Humanity Report
2021 Health for Humanity Report
2021 Health for Humanity Report
ON NOW
2022 Janssen U.S. Transparency Report
2022 Janssen U.S. Transparency Report
2022 Janssen U.S. Transparency Report
ON NOW
2022 Annual Report
2022 Annual Report
Investor Relations
ON NOW
Corporate Governance
Corporate Governance
Corporate Governance
ON NOW
SEC Filings
SEC Filings
SEC Filings
ON NOW
Pharmaceutical Pipeline
Pharmaceutical Pipeline
Pharmaceutical Pipeline
ON NOW
Stock Information
Stock Information
Stock Information
ON NOW
Webcasts & Presentations
Webcasts & Presentations
Webcasts & Presentations
ON NOW
Investor Fact Sheet
Investor Fact Sheet
Investor Fact Sheet
Quarterly Results
See the latest quarterly sales and earnings from Johnson & Johnson, as well as historical results covering the past ten years.
Learn More
Shareholder Tools
Email Alerts Subscription
RSS News Feeds
Investor FAQs
Answers to common questions regarding purchasing and owning Johnson & Johnson stock.
Learn More
ESG Resources
Effective management of ESG matters is a business imperative.
Learn More
Contact Investor Relations
Questions? Please contact us:
1-800-950-5089
investor-relations@its.jnj.com
Learn more about our Guidelines for Communication with the Investment Community (Reg FD)
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue